Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Radiosurgery With Concurrent Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Brain Metastases

NCT04585724 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT04585724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04585724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Radiosurgery With Concurrent Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Brain Metastases
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Withdrawn
Start date
June 12, 2020
Completion date
September 13, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer american joint committee on cancer (ajcc) v8, metastatic breast carcinoma, metastatic malignant neoplasm in the brain, prognostic stage iv breast cancer ajcc v8